Cytokeratin 8/18 levels in patients with prostate cancer and benign prostatic hyperplasia

Urologia Internationalis

Volumn 60, Issue 3, 1998, Pages 152-155

  Wolff, J M ^a   Borchers, H ^a   Brehmer Jr , B ^a   Brauers, A ^a   Jakse, G ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Benign prostatic hyperplasia; Cytokeratin 8 18; Prostate cancer; Tissue polypeptide antigen; Tissue polypeptide specific antigen

Indexed keywords

CYTOKERATIN; TISSUE POLYPEPTIDE ANTIGEN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE HYPERTROPHY; PROSTATECTOMY; PROTEIN BLOOD LEVEL;

ADENOCARCINOMA; AGED; HUMANS; KERATINS; MALE; MIDDLE AGED; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; STATISTICS, NONPARAMETRIC; TUMOR MARKERS, BIOLOGICAL;

EID: 0031818598     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000030240     Document Type: Article

References (16)

1. Moll R, Franke WW, Schiller DL: The catalog of human cytokeratins: Patters of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
2. Steinart PM, Steven AC, Roop DR: The molecular biology of intermediate filaments. Cell 1985;42:411-419.
3. Moll R, Schiller DL, Franke WW: Identification of protein IT of the intestinal cytoskeleton as a novel type I cytokeratin with unusual properties and expression patterns. J Cell Biol 1990;111:567-580.
4. Moll R: Differenzierung und Entdifferenzierung im Spiegel der Intermediärfilament-Expression: Untersuchungen an normalen, alterierten und malignen Epithelien. Verh Dtsch Ges Pathol 1991;75:446-459.
5. Hatzfeld M, Franke WW: Pair formation and promiscuity of cytokeratins: Formation in vitro of heterotypic complexes and intermediatesized filaments by homologous and heterologous recombinations of purified polypeptides. J Cell Biol 1985;101-1826-1841.
6. Quinlan RA, Schiller DL, Hatzfeld M, Achstätter T, Moll R, Jorcano JL, Magin TM, Franke WW: Patterns of expression and organization of cytokeratin intermediate filaments; in Wang E, Fishman D, Liem RRH, Sun TT (eds): Intermediate filaments. Ann NY Acad Sci 1985;455:282-306.
7. Madersbacher S, Schöllhammer A, Kramer G, Steiner G, Marberger M: TPS in prostate cancer. Akt Urol 1993;24:36-39.
8. Marrink J, Oosterom R, Bonfrer HMG, Schröder FH: Tissue polypeptide specific antigen: A discriminative parameter between prostate cancer and benign prostatic hypertrophy. Eur J Cancer 1993;29:570-571.
9. Mellerick DM, Osborn M, Weber K: On the nature of serological TPA: monoclonal keratin 8, 18, and 19 antibodies react differently with TPA prepared from human cultured cells and TPA in serum. Oncogene 1990;5:1007-1017.
10. Sundström B, Stigbrand T: A two-site enzyme-linked immunosorbent assay for cytokeratin 8. Int J Cancer 1990;46:604-607.
11. Björklund B, Björklund V: Antigenicity of pooled human malignant and normal tissues by cytoimmunological technique: Presence of an insoluble heat-labile tumor antigen. Int Arch Allergy 1957;10:153-184.
12. Lüning B, Nilsson U: Sequence homology between TPA and intermediate filament proteins. Acta Chem Scand 1983;B37:731-753.
13. Weber K, Osborn M, Moll R, Wiklund B, Lüning B. Tissue polypeptide antigen is related to the non-epidermal keratins 8, 18 and 19 typical of simple and non-squamous epithelia: Reevaluation of a human tumor marker. EMBO J 1984;3:2707-2714.
14. Bahr J, Carlsson K, Lüning B: An epitope in coil 2B of cytokeratin 8. Acta Chem Scand 1988;B42:442-447.
15. Leube RE, Bosch FX, Romano V, Zimbelmann R, Höfler H, Franke WW: Cytokeratin expression in simple epithelia. III. Detection of mRNAs encoding human cytokeratin Nos 8 and 18 in normal and tumor cells by hybridization with cDNA sequences in vitro and in situ. Differentiation 1986;33:69-85.
16. Björklund B: Tumor markers TPA, TPA-S and cytokeratins. Tumordiagn Ther 1992:13:78-80.